PANACEA BIOTEC LTD. - Update On The USFDA Inspection Of The Company'S Material Wholly-Owned Subsidiary, Panacea Biotec Pharma Limited'S Facility At Baddi, Himachal Pradesh, India
Download 
|
< Back |
| 01 Feb 2024 | |
| Panacea Biotec Pharma Limited has now received a communication from the USFDA on January 31, 2024 indicating the inspection classification as "Official Action Indicated". | |
| View all announcements for PANACEA BIOTEC LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback